Related Experiment Video
Updated: Mar 14, 2026

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Non-alcoholic fatty liver disease.
Non-alcoholic fatty liver disease (NAFLD) is a condition of excess liver fat unrelated to alcohol. Affecting 20-30% of people, its prevalence is rising, making it a significant public health concern.
Area of Science:
- Hepatology
- Gastroenterology
- Public Health
Background:
- Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive fat accumulation in the liver.
- This condition is distinct from liver disease caused by excessive alcohol consumption or other secondary factors like hepatitis C.
- NAFLD is increasingly recognized as a major global health issue.
Purpose of the Study:
- To define Non-alcoholic fatty liver disease (NAFLD) and its key characteristics.
- To highlight the prevalence of fatty liver (steatosis) in the general population.
- To underscore the growing incidence of NAFLD.
Main Methods:
- Information synthesized from National Institute for Health and Care Excellence guidelines.
- Definition and diagnostic criteria for NAFLD established.
- Prevalence data analyzed from population studies.
Main Results:
- NAFLD affects an estimated 20% to 30% of the population.
- The prevalence of fatty liver is on the rise globally.
- Exclusion of alcohol and other secondary causes is critical for NAFLD diagnosis.
Conclusions:
- NAFLD is a common condition with increasing prevalence.
- Understanding the scope of NAFLD is crucial for public health initiatives.
- Further research and clinical attention are warranted for this growing disease.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test